Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.28 USD | -2.58% | -9.59% | +40.43% |
Apr. 15 | CorMedix's DefenCath Now Commercially Available For US Inpatient Use | MT |
Apr. 15 | CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath®? (Taurolidine and Heparin) | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.43% | 290M | |
+1.32% | 67.71B | |
+10.08% | 9.03B | |
-17.63% | 4.71B | |
+0.73% | 3.76B | |
+16.55% | 3.66B | |
+27.76% | 2.55B | |
-26.11% | 2.31B | |
-30.09% | 2.08B | |
+7.15% | 1.94B |
- Stock Market
- Equities
- CRMD Stock
- News CorMedix Inc.
- Earnings Flash (CRMD) CORMEDIX Reports Q4 Revenue $56.4M